Document is current
Any future updates will be listed below
-
Authors
Andres, Philippe https://orcid.org/0000-0003-4706-8099
Winckle, Gareth
Lamquin, Alexandra
Czernielewski, Janusz
-
Funding
Funding for this research was provided by:
French bank of investment BPI
- License Information
-
More Information
Article History
Received: 3 December 2025
Accepted: 5 June 2026
First Online: 12 June 2026
Declarations
Competing interests: The authors of this publication are the founders of Tarian Pharma, the company developing the test product used in the two clinical trials in this publication.
Ethics approval: The two reported studies were performed in line with the principles of the Declaration of Helsinki. Approval of the first study was granted by the Ethics Committee “CPP Sud-Méditerranéen 4” from Montpellier. Approval of the second study was granted by the Ethics Committee “Clinical Research Regulatory Council (CRRC)” from the Republic of Mauritius.
Consent to participate: Informed consent was obtained from all individual participants included in the two studies.
Consent to publish: No individual details, images or videos are included in this manuscript.
